top of page

CARA Study

Study for patients with chronic kidney disease and have itching associated with this condition 


Living with CKD and looking for potential relief from itch?Consider taking part in a study of new investigational study medication. Learn more about the KICK-1 study testing the safety and effectiveness of an investigational oral drug called difelikefalin for those who have chronic kidney disease and have itch associated with this condition.


• Are 18 to 85 years of age

• Have been diagnosed with chronic kidney disease

• Are not currently on dialysis

• Have been experiencing daily or near daily itch for at least 6 months.

**There are other requirements for taking part in this study.**

If you qualify, you may receive at no cost: • Treatment with the investigational oral form of difelikefalin • Close care and follow-up throughout the study Participants will be compensated for taking part in the study


If you’re interested in participating in one of our Research Studies:



ext 2150, 2170 or 2190

bottom of page